1 follower
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together wi... Read more
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
3 followers
Gilead Sciences
152 followers
Regeneron
115 followers
Illumina
76 followers
Agilent Technologies
77 followers
Verily Life Sciences
43 followers
Alexion Pharmaceuticals
42 followers
Explore companies